Kojiro Hata

Development of fulminant hepatitis B (precore variant mutant type) after the discontinuation of low-dose methotrexate therapy in a rheumatoid arthritis patient

Satoshi Ito, Kiyoshi Nakazono, Akira Murasawa et al. · Arthritis & Rheumatism · 2001 · 101 citations

Medicine, Immunology, Pharmacotherapy +15

Safety and efficacy of PD-1 inhibitors in non–small cell lung cancer patients positive for antinuclear antibodies

Yasuto Yoneshima, Kentaro Tanaka, Yoshimasa Shiraishi et al. · Lung Cancer · 2019 · 82 citations

Life Sciences, Oncology, Pharmacology +14

Continuous monitoring of neutrophils to lymphocytes ratio for estimating the onset, severity, and subsequent prognosis of immune related adverse events

Ryosuke Matsukane, Hiroyuki Watanabe, Haruna Minami et al. · Scientific Reports · 2021 · 76 citations · Full text

Life Sciences, Immunology, Oncology +17

Interferon Inhibits Progression of Liver Fibrosis and Reduces the Risk of Hepatocarcinogenesis in Patients with Chronic Hepatitis C: A Retrospective Multicenter Analysis of 652 Patients

Mitsuhiro Takimoto, Shogo Ohkoshi, Takafumi Ichida et al. · Digestive Diseases and Sciences · 2002 · 37 citations

Medicine, Immunology, Pathology +16

Prognostic significance of pre-treatment ALBI grade in advanced non-small cell lung cancer receiving immune checkpoint therapy

Ryosuke Matsukane, Hiroyuki Watanabe, Kojiro Hata et al. · Scientific Reports · 2021 · 37 citations · Full text

Life Sciences, Immunology, Oncology +17